Analysis of cardiovascular disease in Chinese inpatients with chronic kidney disease

Internal Medicine

Volumn 50, Issue 17, 2011, Pages 1797-1801

  Chen, Xiao Nong ^a   Pan, Xiao Xia ^a   Yu, Hai Jin ^a   Shen, Ping Yan ^a   Zhang, Qian Ying ^a   Zhang, Wen ^a   Ren, Hong ^a   Qian, Ying ^a   Zhu, Ping ^a   Chen, Nan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular disease; Chronic kidney disease; Prevalence

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELECTROLYTE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PROTEIN;

ADULT; AGED; ANAPHYLACTOID PURPURA; ARTICLE; BLOOD CELL COUNT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CHEMICAL ANALYSIS; CHINESE; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROLYTE URINE LEVEL; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HOSPITAL PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY INJURY; LABORATORY TEST; LIPID BLOOD LEVEL; LIVER FUNCTION TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PREVALENCE; PROPHYLAXIS; PROTEIN URINE LEVEL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; THORAX RADIOGRAPHY; TREATMENT DURATION; URINALYSIS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 80052403071     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.50.5158     Document Type: Article

References (24)

1. Locatelli F, Bommer J, London GM, et al. Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol Dial Transplant 16: 459-468, 2001.
2. USRDS 2004 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004.
3. Levin A, Djurdjev O, Barrett B, et al. Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. Am J Kidney Dis 38: 1398-1407, 2001.
4. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 16: 101-105, 2003.
5. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 47: 186-192, 1995.
6. Shanghai Dialysis and Transplantation Registration Group. The report about the registration of dialysis and transplantation in Shanghai 1999. Chin J Nephrol 17: 458-463, 2001.
7. Hou FF, Ma ZG, Mei CL, et al. Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey. Natl Med J China 7: 458-463, 2005 (in Chinese).
8. Baron MG. Radiology of the heart. Cecil textbook of medicine 1: 162-170, 1994.
9. Brown WW, Peters RM, Ohmit SE, et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 42: 22-35, 2003.
10. Levin A. Identification of patients and risk factors in chronic kidney disease--evaluating risk factors and therapeutic strategies. Nephrol Dial Transplant 16 (Suppl 7): 57-60, 2001.
11. WHO. International Classification of Diseases (ICD)-9.
12. Kucherer HF, Kuebler WW. Diagnosis of left ventricular hypertrophy by echocardiography. J Cardiovasc Pharmacol 19 (Suppl 5): S81-S86, 1992.
13. Chawla LS, Abell L, Mazhari R, et al. Identifying critically ill patients at high risk for developing acute renal failure: a pilot study. Kidney Int 68: 2274-2280, 2005.
14. Khwaja A, El Kossi M, Floege J, El Nahas M. The management of CKD: a look into the future. Kidney Int 72: 1316-1323, 2007.
15. Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24: 2117-2123, 2009.
16. Zhang L, Zhang P, Wang F, et al. Prevalence and factors associ ated with CKD: a population study from Beijing. Am J Kidney Dis 51: 373-384, 2008.
17. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2 Suppl 1): S1-S266, 2002.
18. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
19. McQueen MJ, Lonn E, Gerstein HC, Bosch J, Yusuf S. The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences. Scand J Clin Lab Invest Suppl 240: 143-156, 2005.
20. Sacks FM, Pfeffer MA, Moye L, et al. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE). Am J Cardiol 68: 1436-1446, 1991.
21. Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41: 47-55, 2003.
22. Nakayama M, Sato T, Sato H, et al. Different clinical outcomes for cardiovascular events and mortality in chronic kidney disease according to underlying renal disease: the Gonryo study. Clin Exp Nephrol 14: 333-339, 2010.
23. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34: 125-134, 1999.
24. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barre PE. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int 54: 1720-1725, 1998.